arrow
A

Antonella Olivero

University of Turin
H指数:24
被引数:1,863

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity

慢性HDV感染显示出比HBV感染更高的HBsAg异构体水平,与HDV复制活性平行

Viruses
IF3.5
2026-04-300
OA
Comparison of diagnostic performances of HDV RNA quantification assays used in clinical practice: results from a national quality control multicenter study

临床实践中HDV RNA定量检测方法的诊断性能比较:一项国家质量控制多中心研究的结果

2025-08-060
OAAI
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm

乙型肝炎病毒感染对原住民和移民的医疗影响:意大利范例

2025-07-290
OAAI
Accurate quantification using the new RoboGene HDV RNA Quantification Kit 3.0: A European multicenter study

使用新的RoboGene HDV RNA Quantification Kit 3.0进行准确定量:一项欧洲多中心研究

2025-06-180
PRE
The glucokinase regulator gene (GCKR) rs780094 C>T single nucleotide polymorphism affect diet response in overweight/obese subjects with metabolic-dysfunction associated steatotic liver disease

葡萄糖激酶调节基因 (GCKR) rs780094 C>T单核苷酸多态性影响患有代谢功能障碍相关脂肪性肝病的超重/肥胖受试者的饮食反应

2024-02-010
PRE
Significant decrease of hepatic steatosis is associated with decreased PAI-I levels in overweight/obese subjects with Metabolic-dysfunction Associated Steatotic Liver Disease

在患有代谢功能障碍相关的脂肪变性肝病的超重/肥胖受试者中,肝脂肪变性的显着减少与pai-i水平降低有关

2024-02-010
PRE
YChrononutrition as a dietary strategy to reduce hepatic steatotis in patients with metabolic dysfunction-associated steatotic liver disease

慢性营养作为一种饮食策略,以减少代谢功能障碍相关的脂肪性肝病患者的肝脂肪炎

2024-02-010
PRE
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

PNPLA3 rs738409基因多态性对非酒精性脂肪性肝病患者肝脏相关事件发生的影响

2023-12-0119
OAAI
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis
2022-10-293
OAAI
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated withBifidobacterium LongumES1 for 8 or 12 Weeks: A Preliminary Report
2020-07-2325
OAAI
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases
2020-03-1535
OAAI